FAQ/Help |
Calendar |
Search |
Today's Posts |
02-28-2017, 01:20 PM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial Yahoo Finance The Phase I clinical study is a dose escalation safety and preliminary efficacy study of ISC-hpNSC®, intracranially transplanted into patients with moderate to severe Parkinson's disease. The open-label, single center, uncontrolled clinical trial will ... and more » More... |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
International Stem Cell Corporation Completes Pre-IND Meeting With FDA for Parkinson' | Parkinson's Disease | |||
International Stem Cell Corporation Announces New Data From Parkinson's Disease Progr | Parkinson's Disease | |||
International Stem Cell Corporation Enters Into Clinical Research Agreement for Parki | Parkinson's Disease | |||
International Stem Cell Corporation to Present Data From Its Parkinson's Disease Prog | Parkinson's Disease | |||
International Stem Cell Corporation Initiates IND-Enabling Study in Parkinson's Disea | Parkinson's Disease |